Table of Contents

Wockhardt Ltd

Updated on March 11, 2025

Stock/Share Code - WOCKPHARMA

Wockhardt is engaged in a Global Pharmaceutical and Biotech Company with presence in USA, UK, Switzerland, Ireland, Mexico, Russia and many other countries.

Below is the details of WOCKPHARMA Wockhardt Ltd

Market Cap	₹3,464 Cr.
Current Price	₹170.95 as on 23 Mar 23
52 Week High / Low Price	₹411.65 / ₹146.7
Face Value	₹5
Stock P/E
Book Value	₹89.82
Dividend Yield	0.00 %
ROCE	-5.27 %
ROE	-18.83 %
Sales Growth (3yrs)	-27.10 %
Sector	Pharmaceuticals
Industry	Pharmaceuticals - Indian - Bulk Drugs & Formln
Listed on	BSE AND NSE
Company Website	Company Website

Pros:

Cons: Stock is trading at 3.48 times its book value Company has low interest coverage ratio. The company has delivered a poor growth of -13.95% over past five years. Company has a low return on equity of -6.33% for last 3 years. Promoters have pledged 26.42% of their holding. Company has high debtors of 385.34 days.

Wockhardt Ltd Price Chart

Wockhardt Ltd Peer Comparison in Pharmaceuticals

S.No.	Name	CMP Rs.	P/E	Mar Cap Rs.Cr.	Div Yld %	NP Qtr Rs.Cr.	Qtr Profit Var %	Qtr Sales Var %	Sales Qtr Rs.Cr.	ROCE %
1.	Sun Pharma.Inds.	₹19.55	28.81	₹124,825.4 Cr.	0.77	-₹1,655.6 Cr.	24.82	-9.42	7585.25	10.53
2.	Dr Reddy's Labs		36.47	₹70,902.77 Cr.	0.59	₹594.6 Cr.	-12.11	14.73	4426.50	11.11
3.		34.95	₹57,535.92 Cr.	0.42	₹577.91 Cr.	20.85	8.95	4346.16	11.77
4.	Aurobindo Pharma		15.87	₹47,396.57 Cr.	0.37	₹780.58 Cr.	20.99	8.82	5924.78	18.73
5.	Biocon		70.21	₹45,138 Cr.	0.13	₹149.4 Cr.	-27.58	14.56	1671.30	13.11
6.	Torrent Pharma.		39.86	₹45,039.6 Cr.	0.64	₹321 Cr.	48.61	1.68	2056.00	15.01
7.	Cadila Health.		26.88	₹38,006.44 Cr.	0.94	₹454 Cr.	49.54	4.11	3639.90	11.83
8.	Wockhardt			₹3,463.79 Cr.	0.00	₹766.39 Cr.	-577.02	-17.28	177.58	-5.27

Ready to Invest?
Talk to our investment specialist

Wockhardt Ltd Fundamentals

Quarterly Results

Quarterly reports are issued by companies every three months. Most companies have a financial year-end of Mar. 31 and quarters that end on June 30, Sept. 30, Dec. 31 and March 31.

Standalone Figures in Rs. Crores

	Sep 2017	Dec 2017	Mar 2018	Jun 2018	Sep 2018	Dec 2018	Mar 2019	Jun 2019	Sep 2019	Dec 2019	Mar 2020	Jun 2020
Sales -	589	535	913	539	635	509	467	215	424	329	162	178
YOY Sales Growth %	-1.56%	-1.88%	68.97%	22.61%	7.75%	-4.96%	-48.83%	-60.20%	-33.14%	-35.36%	-65.30%	-17.28%
Expenses -	536	517	585	499	562	527	476	296	329	340	223	901
Material Cost %	45.50%	44.34%	27.72%	41.16%	42.86%	38.74%	38.77%	38.29%	27.55%	36.20%	36.20%	42.78%
Employee Cost %	21.76%	23.12%	13.54%	25.34%	21.24%	25.87%	16.93%	44.80%	26.48%	32.32%	43.59%	46.22%
Operating Profit	53	19	329	40	72	-18	-8	-81	96	-11	-60	-723
OPM %	9%	3%	36%	7%	11%	-4%	-2%	-38%	23%	-3%	-37%	-407%
Other Income	12	12	11	8	8	6	8	35	2	20	32	1,480
Interest	44	41	42	38	43	42	47	56	54	52	58	59
Depreciation	26	27	27	27	29	30	35	44	42	44	44	46
Profit before tax	-4	-38	270	-17	9	-84	-83	-147	1	-87	-130	652
Tax %	765%	27%	36%	10%	41%	55%	59%	44%	95%	20%	40%	-17%
Net Profit	25	-28	172	-15	5	-38	-34	-83	0	-70	-78	766
EPS in Rs	2.29	-2.49	15.59	-1.37	0.46	-3.46	-3.03	-7.49	0.01	-6.31	-7.08	69.21
	Notes	Notes	Notes	Notes	Notes	Notes	Notes	Notes	Notes	Notes	Notes	Notes

Profit & Loss

The profit and loss (P&L) statement is a financial statement that summarizes the revenues, costs and expenses incurred during a specified period, usually a fiscal quarter or year. The P&L statement is synonymous with the income statement. These records provide information about a company's ability or inability to generate profit" by increasing revenue, reducing costs or both. Some refer to the P&L statement as a statement of profit and loss, income statement, statement of operations, statement of financial results or income, earnings statement or expense statement.

Standalone Figures in Rs. Crores

	Dec 2008	Mar 2010	Mar 2011	Mar 2012	Mar 2013	Mar 2014	Mar 2015	Mar 2016	Mar 2017	Mar 2018	Mar 2019	Mar 2020	TTM
Sales -	1,430	1,849	1,755	2,297	2,203	1,805	1,887	2,217	2,298	2,477	1,557	890	1,093
Sales Growth %	17.04%	29.31%	-5.09%	30.89%	-4.08%	-18.07%	4.50%	17.49%	3.65%	7.82%	-37.13%	-42.85%
Expenses -	1,332	1,636	1,347	1,549	1,864	1,780	1,879	2,091	2,153	2,154	1,619	1,023	1,792
Material Cost %	47.30%	47.07%	46.88%	35.80%	47.10%	44.26%	42.24%	40.86%	41.33%	39.37%	44.56%	35.20%
Manufacturing Cost %	4.46%	3.89%	4.53%	4.77%	7.05%	9.54%	10.42%	9.04%	8.47%	5.27%	10.01%	12.97%
Employee Cost %	9.94%	8.49%	9.80%	9.51%	13.67%	19.64%	21.75%	21.40%	22.81%	20.48%	22.25%	36.67%
Other Cost %	31.44%	29.04%	15.52%	17.35%	16.78%	25.15%	25.20%	23.02%	21.09%	21.85%	27.16%	30.12%
Operating Profit	98	213	408	748	339	25	7	126	145	323	-62	-133	-699
OPM %	7%	12%	23%	33%	15%	1%	0%	6%	6%	13%	-4%	-15%	-64%
Other Income	-388	-703	-276	-83	601	319	465	62	248	57	126	138	1,534
Interest	122	232	203	215	154	34	19	108	169	170	171	220	222
Depreciation	46	71	62	66	81	96	103	99	106	106	120	173	176
Profit before tax	-457	-793	-132	384	706	215	350	-20	119	104	-227	-389	437
Tax %	24%	-0%	0%	52%	12%	8%	5%	143%	-15%	34%	64%	41%
Net Profit	-349	-794	-132	184	623	199	332	8	137	69	-82	-231	618
EPS in Rs					55.97	18.94	30.14	0.75	12.40	6.21	0.00	0.00	55.83
Dividend Payout %	0%	0%	0%	0%	9%	55%	66%	0%	81%	0%	0%	0%

Compounded Sales Growth

10 Years:: -7.05%
5 Years:: -13.95%
3 Years:: -27.10%
TTM:: -40.13%

Compounded Profit Growth

TTM:: -374.05%

Return on Equity

10 Years:: 2.78%
5 Years:: -25.09%
3 Years:: -19.95%
1 Year:: 27.62%

Balance Sheet

A balance sheet is a financial statement that reports a company's assets, liabilities and shareholders' equity at a specific point in time, and provides a basis for computing rates of return and evaluating its capital structure. It is a financial statement that provides a snapshot of what a company owns and owes, as well as the amount invested by shareholders. It is used alongside other important financial statements such as the income statement and statement of cash flows in conducting fundamental analysis or calculating financial ratios.

Standalone Figures in Rs. Crores

	Dec 2008	Mar 2010	Mar 2011	Mar 2012	Mar 2013	Mar 2014	Mar 2015	Mar 2016	Mar 2017	Mar 2018	Mar 2019	Mar 2020
Share Capital -	55	723	800	816	353	353	354	55	55	55	289	55
Preference Capital	-0	669	745	761	299	299	299	-0	-0	-0	234	-0
Equity Capital	55	55	55	55	55	55	55	55	55	55	55	55
Reserves	623	-172	-128	65	763	882	1,016	1,113	1,164	1,239	1,171	939
Borrowings	1,821	1,998	1,896	1,141	174	184	840	1,984	2,120	1,773	1,651	2,301
Other Liabilities -	1,001	1,123	1,177	1,904	2,175	2,271	2,238	1,431	1,230	1,318	1,660	1,464
Trade Payables	283	237	291	370	469	331	344	332	346	446	619	524
Advance from Customers	-0	-0	-0	34	1,052	700	1,272	219	206	80	64	61
Other liability items	718	886	886	1,500	654	1,240	621	880	677	792	978	879
Total Liabilities	3,499	3,004	3,000	3,164	3,167	3,391	4,149	4,584	4,569	4,386	4,538	4,760
Fixed Assets -	715	715	762	856	937	1,033	1,005	1,402	1,465	1,423	1,614	2,044
Gross Block	959	1,032	1,138	1,281	1,436	1,620	1,709	2,206	2,371	2,428	2,740	3,315
Accumulated Depreciation	244	317	376	425	499	587	704	804	906	1,006	1,126	1,271
CWIP	399	463	772	811	482	582	792	664	665	653	381	305
Investments	303	316	308	308	308	308	297	297	297	297	297	297
Other Assets -	2,082	1,510	1,157	1,190	1,441	1,469	2,054	2,221	2,142	2,013	2,245	2,113
Inventories	257	306	305	453	528	484	524	535	535	377	370	315
Trade receivables	459	464	312	261	207	246	210	271	343	800	1,005	940
Cash Equivalents	474	99	162	76	184	86	678	835	660	253	226	157
Loans n Advances	1,076	862	275	130	203	205	194	607	559	525	615	700
Other asset items	-184	-220	104	270	320	447	448	-27	46	58	29	1
Total Assets	3,499	3,004	3,000	3,164	3,167	3,391	4,149	4,584	4,569	4,386	4,538	4,760

Cash Flows

Cash flow is the net amount of cash and cash-equivalents being transferred into and out of a business. At the most fundamental level, a company’s ability to create value for shareholders is determined by its ability to generate positive cash flows, or more specifically, maximize long-term free cash flow.

Standalone Figures in Rs. Crores

	Dec 2008	Mar 2010	Mar 2011	Mar 2012	Mar 2013	Mar 2014	Mar 2015	Mar 2016	Mar 2017	Mar 2018	Mar 2019	Mar 2020
Cash from Operating Activity -	67	-740	480	894	1,429	131	-53	-363	-235	119	58	222
Profit from operations	307	-218	319	870	614	112	55	146	154	355	98	18
Receivables	-50	-78	145	96	66	-72	10	-77	-78	-461	-191	88
Inventory	5	-57	1	-148	-109	43	-40	-12	2	158	3	29
Payables	139	-420	15	105	116	-146	50	-9	22	102	167	-97
Loans Advances	-316	45	2	-30	-74	-50	12	-0	-0	-0	-0	-0
Other WC items	-0	-0	-0	-0	1,023	278	-50	-407	-310	-24	6	184
Working capital changes	-222	-511	163	23	1,022	54	-18	-505	-365	-226	-15	204
Direct taxes	-17	-10	-2	-1	-207	-35	-91	-4	-25	-10	-24	-0
Exceptional CF items	-1	-1	-0	1	-0	-0	-0	-0	-0	-0	-0	-0
Cash from Investing Activity -	-947	667	-181	-236	482	-25	203	-1,015	369	451	120	-16
Fixed assets purchased	-262.65	-147.77	-180.76	-248.99	-180.70	-282.00	-305.04	-280.74	-162.37	-45.08	-25.84	-22.23
Fixed assets sold	0.55	186.93	0.73	1.20	648.30	2.64	9.05	0.11	1.87	0.99	1.75	0.14
Interest received	14.45	10.78	1.36	11.42	34.25	10.50	8.32	37.35	63.74	31.92	9.01	6.18
Dividends received	-0.00	-0.00	-0.00	-0.00	-0.00	195.71	433.81	-0.00	171.11	-0.00	-0.00	-0.00
Invest in subsidiaries	-0.14	-0.00	-0.00	-0.00	-0.00	-0.00	-0.00	-0.00	-0.00	-0.00	-0.05	-0.00
Loans to subsidiaries	-264.66	-0.00	-31.70	-0.40	-0.00	-0.00	-0.00	-0.00	-0.00	-0.00	-0.00	-0.00
Other investing items	-434.83	616.91	29.46	0.54	-20.08	48.39	57.10	-771.44	294.48	462.90	135.46	-0.24
Cash from Financing Activity -	743	103	-207	-743	-1,841	-188	425	764	-133	-524	-69	-274
Proceeds from shares	-0	70	10	-0	2	0	0	0	0	0	0	0
Proceeds from borrowings	1,110	753	142	2	1	11	665	836	120	4	323	4
Repayment of borrowings	-232	-488	-182	-602	-1,174	-2	-2	-2	-2	-399	-239	-268
Interest paid fin	-103	-231	-177	-142	-319	-33	-19	-70	-141	-128	-132	-148
Dividends paid	-32	-0	-0	-0	-0	-164	-220	-0	-110	-0	-0	-0
Financial liabilities	-0	-0	-0	-0	-0	-0	-0	-0	-0	-0	-0	-70
Other financing items	-0	-0	-0	-0	-351	-0	-0	-0	-0	-0	-21	209
Net Cash Flow	-138	30	92	-85	70	-81	575	-614	1	46	109	-69

Ready to Invest?
Talk to our investment specialist

Ratios

	Dec 2008	Mar 2010	Mar 2011	Mar 2012	Mar 2013	Mar 2014	Mar 2015	Mar 2016	Mar 2017	Mar 2018	Mar 2019	Mar 2020
ROCE %	5%	15%	14%	33%	34%	18%	20%	3%	9%	9%	-2%	-5%
Debtor Days	117	92	65	41	34	50	41	45	54	118	236	385
Inventory Turnover	2.74	3.23	2.83	2.34	2.28	1.71	1.73	1.87	1.93	2.26	2.04	1.09

Announcements & News

Recent Announcements

Credit Ratings

Wockhardt Limited Aug 27 from care
Wockhardt Limited Feb 25 from care
India Ratings Places Wockhardt on RWE Feb 24 from fitch
Wockhardt Limited 30 Sep 2019 from care
India Ratings Downgrades Wockhardt to ‘IND BB+’; Outlook Negative 28 Aug 2019 from fitch
India Ratings Downgrades Wockhardt to ‘IND BBB-’; Outlook Negative 29 Mar 2019 from fitch

Annual Reports

How to Invest in Mutual Funds SIP Online?

Open Free Investment Account for Lifetime at Fincash.com.
Complete your Registration and KYC Process
Upload Documents (PAN, Aadhaar, etc.). And, You are Ready to Invest! Get Started
Invest in Mutual Funds which invests in Wockhardt Ltd & Get More Returns than Bank Deposit

Disclaimer:
All efforts have been made to ensure the information provided here is accurate as per time to time filling by company to exchanges. However, no guarantees are made regarding correctness of data. Investors are advised to validate/check information with exchanges or companies website before making any investment decisions.

Shepard Technologies Pvt. Ltd : 1808, Solus, Hiranandani Estate, Thane, Maharashtra - 400607

AMFI Registration No. 112358 | CIN: U74999MH2016PTC282153

Mutual fund investments are subject to market risks. Please read the scheme information and other related documents carefully before investing. Past performance is not indicative of future returns. Please consider your specific investment requirements before choosing a fund, or designing a portfolio that suits your needs.

Shepard Technologies Pvt. Ltd. (with ARN code 112358) makes no warranties or representations, express or implied, on products offered through the platform. It accepts no liability for any damages or losses, however caused, in connection with the use of, or on the reliance of its product or related services. Terms and conditions of the website are applicable.